Nextcure logo

Nextcure share price today

(NXTC)

Nextcure share price is $0.97 & ₹82.43 as on 21 Dec 2024, 2.30 'hrs' IST

$0.97

0.02

(2.11%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Nextcure share price in Dollar and Rupees. Guide to invest in Nextcure from India. Also see the sentimental analysis on Indian investors investing in Nextcure. Get details on the Indian mutual funds that are investing in Nextcure. Get Analyst recommendations and forecasts along with all the Nextcure's financials.

Nextcure share price movements

  • Today's Low: $0.93
    Today's High: $0.99

    Day's Volatility :5.92%

  • 52 Weeks Low: $0.87
    52 Weeks High: $2.57

    52 Weeks Volatility :66.14%

Nextcure Returns

PeriodNextcure IncIndex (Russel 2000)
3 Months
-32.14%
0.0%
6 Months
-43.45%
0.0%
1 Year
-17.39%
0.0%
3 Years
-83.95%
-17.3%

Nextcure Key Statistics

in dollars & INR

Previous Close
$0.95
Open
$0.93
Today's High
$0.9885
Today's Low
$0.93
Market Capitalization
$24.9M
Today's Volume
$48.7K
52 Week High
$2.57
52 Week Low
$0.8702
Revenue TTM
$0.0
EBITDA
$-60.4M
Earnings Per Share (EPS)
$-2.1
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-54.75%

How to invest in Nextcure from India?

It is very easy for Indian residents to invest directly in Nextcure from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nextcure stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nextcure or NXTC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nextcure or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nextcure shares which would translate to 0.876 fractional shares of Nextcure as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Nextcure, in just a few clicks!

Returns in Nextcure for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nextcure investment value today

Current value as on today

₹1,17,748

Returns

₹17,748

(+17.75%)

Returns from Nextcure Stock

₹15,652 (false-15.65%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Nextcure

171%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Nextcure on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 171% more investors are searching Nextcure in the last 30 days versus the previous period.

Global Institutional Holdings in Nextcure

  • Sofinnova Ventures

    9.54%

  • Logos Global Management LP

    8.93%

  • Affinity Asset Advisors, LLC

    8.22%

  • Orbimed Advisors, LLC

    4.07%

  • Vanguard Group Inc

    3.53%

  • BlackRock Inc

    2.72%

Analyst Recommendation on Nextcure

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Nextcure(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Nextcure

What analysts predicted

Upside of 243.64%

Current:

$0.97

Target:

$3.33

Insights on Nextcure

  • Price Movement

    In the last 7 days, NXTC stock has moved down by -12.0%
  • NXTC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 50.1%
  • NXTC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 20.5% return, outperforming this stock by 103.9%

Nextcure Technicals Summary

Sell

Neutral

Buy

Nextcure is currently in a neutral trading position according to technical analysis indicators.

Nextcure Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nextcure Inc
-26.92%
-43.45%
-17.39%
-83.95%
-98.56%
Regeneron Pharmaceuticals, Inc.
-4.72%
-33.43%
-16.35%
14.7%
89.27%
Biontech Se
9.01%
28.55%
5.71%
-57.13%
220.59%
Alnylam Pharmaceuticals, Inc.
-3.99%
7.16%
25.05%
27.48%
103.59%
Vertex Pharmaceuticals Incorporated
-12.1%
-16.49%
-2.12%
78.05%
80.31%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nextcure Inc
NA
NA
NA
-1.97
-0.55
-0.31
NA
4.1
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.05
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nextcure Inc
Buy
$24.9M
-98.56%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
89.27%
17.67
33.61%
Biontech Se
Buy
$26.8B
220.59%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.7B
103.59%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$115.2B
80.31%
32.84
-4.51%

About Nextcure

nextcure, inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. its lead product candidate is nc318, which is in phase 2 clinical trials for the treatment of advanced or metastatic solid tumors. the company is also developing nc410, is a novel immunomedicine designed to block immune suppression mediated by an immune modulator called leukocyte-associated immunoglobulin-like receptor 1. its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules that targets a novel member of the b7-family of immunomodulatory proteins; and an antibody in preclinical development targeting an immune modulator that is expressed in inflamed tissue and the tumor microenvironment in various tumor types. nextcure, inc. has a license agreement with yale university; and a research and development col
Organization
Nextcure
Employees
82
CEO
Mr. Michael S. Richman MSBA
Industry
Biotechnology

Management People of Nextcure

NameTitle
Mr. Michael S. Richman MSBA
Co-Founder, CEO, President & Director
Dr. Solomon Langermann Ph.D.
Chief Scientific Officer
Dr. Lieping Chen M.D., Ph.D.
Co-Founder & Chairman of Scientific Advisory Board
Mr. Steven P. Cobourn CPA
Chief Financial Officer
Dr. Timothy Mayer Ph.D.
Chief Operating Officer
Mr. Kevin G. Shaw
Senior VP & General Counsel
Mr. Sourav Kundu Ph.D.
Senior Vice President of Development & Manufacturing
Dr. Sebastien Maloveste Ph.D.
Senior Vice President of Business Development
Dr. Udayan Guha M.D., Ph.D.
Senior Vice President of Clinical & Translational Development

Important FAQs about investing in Nextcure from India :

What is Nextcure share price today?

Nextcure share price today stands at $0.97, Open: $0.93 ; Previous Close: $0.95 ; High: $0.99 ; Low: $0.93 ; 52 Week High: $2.57 ; 52 Week Low: $0.87. The stock opens at $0.93, after a previous close of $0.95. The stock reached a daily high of $0.99 and a low of $0.93, with a 52-week high of $2.57 and a 52-week low of $0.87.

Can Indians buy Nextcure shares?

Yes, Indians can invest in the Nextcure (NXTC) from India.

With INDmoney, you can buy Nextcure at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nextcure at zero transaction cost.

How can I buy Nextcure shares from India?

It is very easy to buy Nextcure from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nextcure be purchased?

Yes, you can buy fractional shares of Nextcure with INDmoney app.

What are the documents required to start investing in Nextcure stocks?

To start investing in Nextcure, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nextcure

Today’s highest price of Nextcure (NXTC) is $0.99.

Today’s lowest price of Nextcure (NXTC) is $0.93.

What is today's market capitalisation of Nextcure

Today's market capitalisation of Nextcure NXTC is 24.9M

What is the 52 Week High and Low Range of Nextcure

  • 52 Week High

    $2.57

  • 52 Week Low

    $0.87

What are the historical returns of Nextcure?

  • 1 Month Returns

    -26.92%

  • 3 Months Returns

    -43.45%

  • 1 Year Returns

    -17.39%

  • 5 Years Returns

    -98.56%

Who is the Chief Executive Officer (CEO) of Nextcure

Mr. Michael S. Richman MSBA is the current Chief Executive Officer (CEO) of Nextcure.